L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report. 2015

Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat

L-asparaginase (L-Asp) is an essential component of acute lymphoblastic leukemia (ALL) treatment protocols and its use has been associated with many adverse effects. We report a case of a 15-year-old boy with ALL who developed L-Asp induced hypoglycemia. To the best of our knowledge, only one such case has been reported previously.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001215 Asparaginase A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1. Asparaginase II,Asparaginase medac,Asparagine Deaminase,Colaspase,Crasnitin,Elspar,Erwinase,Kidrolase,Leunase,Paronal,Deaminase, Asparagine,medac, Asparaginase
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
April 2012, Experimental hematology & oncology,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
March 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
July 2012, Journal of pharmacology & pharmacotherapeutics,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
July 2020, Internal medicine (Tokyo, Japan),
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
February 1998, Singapore medical journal,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
January 1998, Pediatric hematology and oncology,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
January 1996, Haematologica,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
July 2020, Clinical case reports,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
March 2010, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Raiz Ahmad Misgar, and Bashir Ahmad Laway, and Sk Hammadur Rahaman, and Arshad Iqbal Wani, and Mir Iftikhar Bashir, and Javeed Rasool Bhat
January 2014, Indian journal of cancer,
Copied contents to your clipboard!